安旭生物11月11日获融资买入738.67万元，融资余额9448.65万元

Group 1 - On November 11, Anxu Bio's stock rose by 4.39%, with a transaction volume of 99.73 million yuan [1] - The financing data for Anxu Bio on the same day showed a financing purchase amount of 7.39 million yuan and a financing repayment of 11.37 million yuan, resulting in a net financing outflow of 3.99 million yuan [1] - As of November 11, the total balance of margin trading for Anxu Bio was 94.49 million yuan, which is 1.75% of its circulating market value, indicating a low financing balance compared to the past year [1] Group 2 - As of September 30, Anxu Bio had 6,090 shareholders, an increase of 1.10% from the previous period, while the average circulating shares per person decreased by 1.08% to 20,867 shares [2] - For the period from January to September 2025, Anxu Bio reported operating revenue of 325 million yuan, a year-on-year decrease of 19.34%, and a net profit attributable to shareholders of 64.36 million yuan, down 52.60% year-on-year [2] - Since its A-share listing, Anxu Bio has distributed a total of 895 million yuan in dividends, with 657 million yuan distributed over the past three years [2]